These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34536214)

  • 21. Impact of China's COVID-19 prevention and control efforts on outbreaks of influenza.
    Li Q; Wang J; Lv H; Lu H
    Biosci Trends; 2021 Jul; 15(3):192-195. PubMed ID: 34176827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study on the Experience of Public Health System Construction in China's COVID-19 Prevention.
    Zhang P
    Front Public Health; 2021; 9():610824. PubMed ID: 33981659
    [No Abstract]   [Full Text] [Related]  

  • 23. [COVID-19 pandemic: global epidemiological trends and China's subsequent preparedness and responses].
    Guo Y; Huang YM; Huang J; Jin YZ; Jiang W; Liu PL; Liu FJ; Ma JX; Ma JY; Wang Y; Xie Z; Yin H; Zhao CS; Zhou SD; Zhang J; Zheng ZJ;
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 May; 41(5):642-647. PubMed ID: 32164401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations.
    Huang M; Wang J; Nicholas S; Maitland E; Guo Z
    J Med Internet Res; 2021 Jun; 23(6):e27345. PubMed ID: 34061761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Early containment strategies and core measures for prevention and control of novel coronavirus pneumonia in China].
    Chen W; Wang Q; Li YQ; Yu HL; Xia YY; Zhang ML; Qin Y; Zhang T; Peng ZB; Zhang RC; Yang XK; Yin WW; An ZJ; Wu D; Yin ZD; Li S; Chen QL; Feng LZ; Li ZJ; Feng ZJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Mar; 54(3):239-244. PubMed ID: 32064856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ongoing COVID-19 Pandemic: A Concise but Updated Comprehensive Review.
    Wang C; Xiao X; Feng H; Hong Z; Li M; Tu N; Li X; Wang K; Bu L
    Curr Microbiol; 2021 May; 78(5):1718-1729. PubMed ID: 33847795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "A community system": A critical foundation for the epidemic prevention and control of SARS-CoV-2.
    Zhang X; Yang S
    Int J Health Plann Manage; 2020 Sep; 35(5):1246-1249. PubMed ID: 32677114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulating China's health code system to prepare for future pandemics.
    Shen T; Wang C
    Front Public Health; 2023; 11():1208615. PubMed ID: 37841734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The dynamic COVID-zero strategy on prevention and control of COVID-19 in China].
    Liang WN; Liu M; Liu J; Wang YD; Wu J; Liu X
    Zhonghua Yi Xue Za Zhi; 2022 Jan; 102(4):239-242. PubMed ID: 35073672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the beginning of a pandemic: China's response to the emergence of COVID-19.
    Yu X; Li N
    J Infect Public Health; 2021 Mar; 14(3):347-352. PubMed ID: 33618279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The COVID-19 pandemic in China: from dynamic zero-COVID to current policy.
    Ge J
    Herz; 2023 Jun; 48(3):226-228. PubMed ID: 37294456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Impact of China's Legal System on Public Health and Quality of Life during the COVID-19 Pandemic: An Empirical Study.
    Duan W; Qin T
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferential Tax Policies: An Invisible Hand behind Preparedness for Public Health Emergencies.
    Fan Y; Yang S; Jia P
    Int J Health Policy Manag; 2022 May; 11(5):547-550. PubMed ID: 32729287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Core policies disparity response to COVID-19 among BRICS countries.
    Jiao J; Shi L; Zhang Y; Chen H; Wang X; Yang M; Yang J; Liu M; Sun G
    Int J Equity Health; 2022 Jan; 21(1):9. PubMed ID: 35057810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling and interpreting the COVID-19 intervention strategy of China: A human mobility view.
    Chen H; He J; Song W; Wang L; Wang J; Chen Y
    PLoS One; 2020; 15(11):e0242761. PubMed ID: 33232385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research on International Cooperative Governance of the COVID-19.
    Lin X; Yang H; Wu Y; Zheng X; Xie L; Shen Z; Hu S
    Front Public Health; 2021; 9():566499. PubMed ID: 33996704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International Trade of Masks and COVID-19 Pandemic Containment.
    Fan X; Li B; Xiu Y
    J Environ Public Health; 2022; 2022():2156950. PubMed ID: 35855816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of China's Prevention and Control Strategy for the COVID-19 Epidemic.
    Wang J; Wang Z
    Int J Environ Res Public Health; 2020 Mar; 17(7):. PubMed ID: 32225019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective mitigation strategy in early stage of COVID-19 pandemic in China.
    Yu XY; Xu C; Wang HW; Chang RJ; Dong YQ; Tsamlag L; Zhang SX; Yu YL; Long RS; Wang H; Cai Y
    Infect Dis Poverty; 2020 Oct; 9(1):141. PubMed ID: 33046120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concerns Expressed by Chinese Social Media Users During the COVID-19 Pandemic: Content Analysis of Sina Weibo Microblogging Data.
    Wang J; Zhou Y; Zhang W; Evans R; Zhu C
    J Med Internet Res; 2020 Nov; 22(11):e22152. PubMed ID: 33151894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.